Blockage of Ephrin-B2 signaling with the extracellular domain of EphB4 fused with human serum albumin (sEphB4-HSA), suppressed a wide variety of tumors including KS [19], [20], [31], [89], [90]. The gene discussed is ALB; the disease is Kaposi's sarcoma.